Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence based review on levosalbutamol.

Mukesh Kumar Gupta1, Meenu Singh

  • 1Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India. mukesh_dhonkaria@yahoo.co.in

Indian Journal of Pediatrics
|March 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunomodulatory Roles of Probiotics: From Intestinal Barrier Regulation to Clinical Applications.

Current pharmaceutical biotechnology·2026
Same author

Acrodermatitis Enteropathica Like Rash in an Infant - Can Cystic Fibrosis be the Culprit When Zinc Isn't?

Indian journal of pediatrics·2026
Same author

Large scale multi-class pest image classification using structurally adapted DenseNet architecture.

Scientific reports·2026
Same author

Exosome-facilitated nanoplatform for enhanced antibiotic delivery to eradicate intracellular multidrug-resistant Escherichia coli in neonatal sepsis.

International journal of pharmaceutics·2026
Same author

Efficacy and safety of remdesivir for patients with severe acute respiratory syndrome coronavirus 2 infection: A systematic review of randomized controlled trials.

Indian journal of pharmacology·2026
Same author

Mechanistic paradigms of teratogenicity induced by metallic nanoparticles-a mini review.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2025

Levosalbutamol, the active R-isomer of salbutamol, offers therapeutic advantages over racemic salbutamol. Studies suggest S-salbutamol may have adverse effects, necessitating further research on levosalbutamol

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Respiratory Medicine

Background:

  • Salbutamol, a common bronchodilator, is a chiral drug existing as R- (levosalbutamol) and S-isomers.
  • The standard formulation is a racemic mixture containing both isomers.
  • Levosalbutamol possesses the therapeutic beta 2 agonist activity, while S-salbutamol was previously considered inert.

Purpose of the Study:

  • To evaluate the therapeutic potential and safety of levosalbutamol compared to racemic salbutamol.
  • To investigate the effects of S-salbutamol, challenging its inert status.
  • To explore the implications of enantioselective metabolism on salbutamol efficacy.

Main Methods:

  • Review of existing animal and human studies on salbutamol isomers.
  • Analysis of clinical trial data comparing levosalbutamol and racemic salbutamol.

Related Experiment Videos

  • Pharmacokinetic evaluation of enantioselective metabolism of salbutamol.

    • Main Results:

    • S-salbutamol is not inert and may exert deleterious effects.
    • Enantioselective metabolism can lead to elevated S-salbutamol plasma levels with repeated dosing.
    • Levosalbutamol formulations show therapeutic advantages and potential cost-effectiveness in clinical trials.

    Conclusions:

    • Chronic use of racemic salbutamol may lead to reduced effectiveness and clinical deterioration.
    • Levosalbutamol (R-isomer) presents a promising alternative to racemic salbutamol for asthma treatment.
    • Further large-scale multicenter trials are required to confirm the long-term therapeutic superiority and cost-effectiveness of levosalbutamol.